• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白细胞介素-6抑制剂在严重全身炎症反应综合征所致血管麻痹性休克中的应用:一例报告

The Use of an Interleukin-6 Inhibitor in Vasoplegic Shock from Severe Systemic Inflammatory Response Syndrome: A Case Report.

作者信息

Elkhatib Wiaam Y, Saunders Hollie, Helgeson Scott A, Moss John E

机构信息

Department of Internal Medicine, Mayo Clinic, Jacksonville, Florida, United States.

Department of Pulmonary and Critical Care Medicine, Mayo Clinic, Jacksonville, Florida, United States.

出版信息

Indian J Crit Care Med. 2021 Aug;25(8):939-941. doi: 10.5005/jp-journals-10071-23943.

DOI:10.5005/jp-journals-10071-23943
PMID:34733038
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8559756/
Abstract

A 66-year-old Caucasian male with a history of chronic myelomonocytic leukemia (CMML) developed fluid-unresponsive hypotension requiring initiation of four different maximum dosed vasopressors, steroids, and broad-spectrum antibiotics 4 hours following four-vessel coronary artery bypass grafting involving a 150-minute cardiac bypass. Placement of a Swanz-Ganz catheter showed a cardiac output of 7 L/minute with systemic vascular resistance of 571 dynes/sec/cm. Over 24 hours, three doses of tocilizumab (interleukin-6 inhibitor) every 8 hours were initiated, plus 250 mg methylprednisolone per 6 hours increment, and then daily thereafter. After the initial dose of tocilizumab, it was possible to wean vasoconstrictors. We have shown for the first time that therapy with tocilizumab is effective in reversing the hemodynamic instability associated with the significant systemic inflammatory response from the "double hit" of CMML and coronary artery bypass grafting with cardiopulmonary bypass as has previously been shown in cytokine release syndrome. Elkhatib WY, Saunders H, Helgeson SA, Moss JE. The Use of an Interleukin-6 Inhibitor in Vasoplegic Shock from Severe Systemic Inflammatory Response Syndrome: A Case Report. Indian J Crit Care Med 2021;25(8):939-941.

摘要

一名66岁的患有慢性粒单核细胞白血病(CMML)的白人男性,在进行了长达150分钟体外循环的四支血管冠状动脉搭桥术后4小时,出现了对液体无反应的低血压,需要开始使用四种不同的最大剂量血管加压药、类固醇和广谱抗生素。放置Swan-Ganz导管显示心输出量为7升/分钟,全身血管阻力为571达因/秒/厘米。在24小时内,每8小时开始使用三剂托珠单抗(白细胞介素-6抑制剂),每6小时增加250毫克甲泼尼龙,此后每天使用。在首次使用托珠单抗后,有可能逐渐减少血管收缩剂的用量。我们首次表明,托珠单抗治疗可有效逆转与CMML和冠状动脉搭桥术加体外循环的“双重打击”所导致的显著全身炎症反应相关的血流动力学不稳定,正如之前在细胞因子释放综合征中所显示的那样。埃尔卡提卜·WY、桑德斯·H、赫尔格森·SA、莫斯·JE。白细胞介素-6抑制剂在严重全身炎症反应综合征所致血管麻痹性休克中的应用:一例报告。《印度重症监护医学杂志》2021年;25(8):939 - 941。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03fc/8559756/504622d51209/ijccm-25-939-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03fc/8559756/d10de8772b12/ijccm-25-939-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03fc/8559756/504622d51209/ijccm-25-939-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03fc/8559756/d10de8772b12/ijccm-25-939-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03fc/8559756/504622d51209/ijccm-25-939-g002.jpg

相似文献

1
The Use of an Interleukin-6 Inhibitor in Vasoplegic Shock from Severe Systemic Inflammatory Response Syndrome: A Case Report.白细胞介素-6抑制剂在严重全身炎症反应综合征所致血管麻痹性休克中的应用:一例报告
Indian J Crit Care Med. 2021 Aug;25(8):939-941. doi: 10.5005/jp-journals-10071-23943.
2
Perioperative infusion of low- dose of vasopressin for prevention and management of vasodilatory vasoplegic syndrome in patients undergoing coronary artery bypass grafting-A double-blind randomized study.冠状动脉搭桥术患者围手术期输注低剂量血管加压素预防和治疗血管扩张性血管麻痹综合征——一项双盲随机研究
J Cardiothorac Surg. 2010 Mar 28;5:17. doi: 10.1186/1749-8090-5-17.
3
Use of Intravenous Hydroxocobalamin without Methylene Blue for Refractory Vasoplegic Syndrome After Cardiopulmonary Bypass.心肺转流术后难治性血管扩张性休克使用羟钴胺静脉注射而不使用亚甲蓝。
Am J Case Rep. 2021 Jun 18;22:e930890. doi: 10.12659/AJCR.930890.
4
Urgent Coronary Artery Bypass Surgery in a Patient with Postinfarction Angina and Active Myelomonocytic Leukaemia.一名患有心肌梗死后心绞痛和活动性骨髓单核细胞白血病患者的紧急冠状动脉搭桥手术
Case Rep Oncol. 2016 Nov 18;9(3):781-785. doi: 10.1159/000452791. eCollection 2016 Sep-Dec.
5
Human cytokine responses to coronary artery bypass grafting with and without cardiopulmonary bypass.人体对有或无体外循环冠状动脉旁路移植术的细胞因子反应。
Ann Thorac Surg. 1999 Oct;68(4):1330-5. doi: 10.1016/s0003-4975(99)00729-8.
6
Vasoplegic syndrome after off-pump coronary artery bypass surgery.
Eur J Cardiothorac Surg. 2003 Feb;23(2):165-9. doi: 10.1016/s1010-7940(02)00734-0.
7
Human cytokine responses to cardiac transplantation and coronary artery bypass grafting.人类细胞因子对心脏移植和冠状动脉旁路移植术的反应。
J Thorac Cardiovasc Surg. 1996 Feb;111(2):469-77. doi: 10.1016/s0022-5223(96)70458-0.
8
Surgical trauma affects the proinflammatory status after cardiac surgery to a higher degree than cardiopulmonary bypass.手术创伤对心脏手术后促炎状态的影响程度高于体外循环。
J Thorac Cardiovasc Surg. 2005 Apr;129(4):760-6. doi: 10.1016/j.jtcvs.2004.07.052.
9
Patterns of postoperative systemic vascular resistance in a randomized trial of conventional on-pump versus off-pump coronary artery bypass graft surgery.
Ann Thorac Surg. 2006 Oct;82(4):1436-44. doi: 10.1016/j.athoracsur.2006.04.053.
10
Does high-dose methylprednisolone in aprotinin-treated patients attenuate the systemic inflammatory response during coronary artery bypass grafting procedures?
J Cardiothorac Vasc Anesth. 1999 Apr;13(2):165-72. doi: 10.1016/s1053-0770(99)90081-2.

引用本文的文献

1
Vasoplegic Syndrome after Cardiac Surgery for Infective Endocarditis.感染性心内膜炎心脏手术后的血管麻痹综合征
J Clin Med. 2022 Sep 21;11(19):5523. doi: 10.3390/jcm11195523.

本文引用的文献

1
TET2 Function in Hematopoietic Malignancies, Immune Regulation, and DNA Repair.TET2在血液系统恶性肿瘤、免疫调节及DNA修复中的作用
Front Oncol. 2019 Apr 2;9:210. doi: 10.3389/fonc.2019.00210. eCollection 2019.
2
Leukemoid reaction in chronic myelomonocytic leukemia patients undergoing surgery: perioperative management recommendations.慢性粒单核细胞白血病患者手术时出现类白血病反应:围手术期管理建议。
Blood Adv. 2019 Apr 9;3(7):952-955. doi: 10.1182/bloodadvances.2019032300.
3
Cytokine release syndrome.细胞因子释放综合征。
J Immunother Cancer. 2018 Jun 15;6(1):56. doi: 10.1186/s40425-018-0343-9.
4
Chronic myelomonocytic leukemia: 2018 update on diagnosis, risk stratification and management.慢性粒单核细胞白血病:2018年诊断、风险分层与管理更新
Am J Hematol. 2018 Jun;93(6):824-840. doi: 10.1002/ajh.25104.
5
Hemolysis and Inflammatory Response to Extracorporeal Circulation during On-Pump CABG: Comparison between Roller and Centrifugal Pump Systems.体外循环冠状动脉搭桥术中溶血及炎症反应:滚压泵与离心泵系统的比较
Braz J Cardiovasc Surg. 2018 Jan-Feb;33(1):64-71. doi: 10.21470/1678-9741-2017-0125.
6
Evidence of systemic cytokine release in patients undergoing cardiopulmonary bypass.体外循环患者全身细胞因子释放的证据。
J Extra Corpor Technol. 2005 Sep;37(3):272-7.
7
Organ dysfunction and cardiopulmonary bypass: the role of complement and complement regulatory proteins.器官功能障碍与体外循环:补体及补体调节蛋白的作用
Eur J Cardiothorac Surg. 1993;7(11):563-73. doi: 10.1016/1010-7940(93)90241-3.